Discover 1,955 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
for
Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation,
Location: Dallas TX, Houston TX, Lexington KY, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: Male
Age: 18+
Code: NCT05691465
Phase 2, Recruiting
Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
for
Acute Myeloid Leukemia
Location: Dallas TX, Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT04659616
Phase 1, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Allen TX, Dallas TX, Carrollton TX, DeSoto TX,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
for
Duchenne Muscular Dystrophy
Location: Flower Mound TX, Little Rock AR, St Louis MO,
Sponsor: Sarepta Therapeutics, Inc.
Sex: Male
Age: 2+
Code: NCT04626674
Phase 1, Recruiting
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
for
Muscular Atrophy, Spinal
Location: Flower Mound TX, Chicago IL, Norfolk VA
Sponsor: Biogen
Sex: All
Age: 0
Code: NCT07221669
Phase 3, Recruiting
A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
Location: Flower Mound TX, Philadelphia PA, Seattle WA
Sponsor: CSL Behring
Sex: All
Age: 2 - 17
Code: NCT03684018
Recruiting
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
for
Sjögren's Syndrome
Location: Colleyville TX, The Woodlands TX, Tomball TX, Katy TX,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT06747949
Phase 3, Recruiting
New
Study of PTC844 in Participants With Active Rheumatoid Arthritis
for
Rheumatoid Arthritis
Location: Irving TX, Chandler AZ, Winter Park FL, Miami FL,
Sponsor: PTC Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07779616
Phase 2, Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Fort Worth TX, Houston TX, Aurora CO, Atlanta GA,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07659782
Phase 2, Recruiting
Venous Compression in Fontan
for
Single-ventricle, Fontan Circulation
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 45
Code: NCT07220226
Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Dallas TX, Austin TX, San Antonio TX, Little Rock AR,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,